
|Videos|September 9, 2021
Examining new biological treatments in posterior uveitis
Author(s)Sheryl Stevenson, OT Staff Reports
Quan Dong Nguyen, MD, MSc, FARVO, FASRS, highlights his presentation regarding new biological treatments of posterior uveitis.
Advertisement
Quan Dong Nguyen, MD, MSc, FARVO, FASRS, director of the Uveitis and Ocular Inflammation Service, Byers Eye Institute, Stanford University School of Medicine, speaks on the highlights of his presentation regarding new biological treatments of posterior uveitis.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retina Society 2026: Medium-dose OCU410 gene therapy cuts geographic atrophy progression by up to 32% in phase 2 trial
2
Retina Society 2026: SOL-1 shows intravitreal axitinib hydrogel superior to aflibercept in wet AMD
3
Retina Society 2026: Ocular syphilis, HIV co-infection, and RPR titers
4
Retina Society 2026: How blood biomarkers may predict GA speed
5











